Novel Curcumin Analogue L6H4 in Treating Liver Fibrosis and Type 2 Diabetes

References

• Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799–806. doi:10.1038/414799a
   PubMed Web of Science ®Google Scholar
• Takamura T, Misu H, Ota T, Kaneko S. Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver. Endocr J. 2012;59(9):745–763. doi:10.1507/endocrj.EJ12-0228
   PubMed Web of Science ®Google Scholar
• Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of nonalcoholic fatty liver disease. Qjm. 2010;103(2):71–83. doi:10.1093/qjmed/hcp158
   PubMed Web of Science ®Google Scholar
• Sakurai M, Sasaki M, Ota T, et al. Liver steatosis, but not fi brosis, is associated with insulin resistance in nonalcoholic fatty liver disease. J Gastroenterol. 2007;42(4):312–317. doi:10.1007/s00535-006-1948
   PubMed Web of Science ®Google Scholar
• Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106(36):15430–15435. doi:10.1073/pnas.0904944106
   PubMed Web of Science ®Google Scholar
• Zhang DW, Fu M, Gao SH, Liu JL. Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. 2013;2013:636053. doi:10.1155/2013/636053
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012;39(3):283–299. doi:10.1111/j.1440-1681.2011.05648.x
   PubMed Web of Science ®Google Scholar
• Maithili Karpaga Selvi N, Sridhar MG, Swaminathan RP, Sripradha R. Curcumin attenuates oxidative stress and activation of redox-sensitive kinases in high fructose- and high-fat-fed male Wistar rats. Sci Pharm. 2015;83(1):159–175. doi:10.3797/scipharm.1408-16
   PubMedGoogle Scholar
• Kim BH, Lee ES, Choi R, et al. Protective effects of curcumin on renal oxidative stress and lipid metabolism in a rat model of type 2 diabetic nephropathy. Yonsei Med J. 2016;57(3):664–673. doi:10.3349/ymj.2016.57.3.664
   PubMed Web of Science ®Google Scholar
• Ibrahim ZS, Alkafafy ME, Ahmed MM, Soliman MM. Renoprotective effect of curcumin against the combined oxidative stress of diabetes and nicotine in rats. Mol Med Rep. 2016;13(4):3017–3026. doi:10.3892/mmr.2016.4922
   PubMed Web of Science ®Google Scholar
• Ho C, Hsu YC, Lei CC, Mau SC, Shih YH, Lin CL. Curcumin rescues diabetic renal fibrosis by targeting superoxide-mediated wnt signaling pathways. Am J Med Sci. 2016;351(3):286–295. doi:10.1016/j.amjms.2015.12.017
   PubMed Web of Science ®Google Scholar
• Pithadia AS, Bhunia A, Sribalan R, Padmini V, Fierke CA, Ramamoorthy A. Influence of a curcumin derivative on hIAPP aggregation in the absence and presence of lipid membranes. Chem Commun. 2016;52(5):942–945. doi:10.1039/C5CC07792C
   PubMed Web of Science ®Google Scholar
• Hackler L, Ozsvari B, Gyuris M, et al. The curcumin analog C-150, Influencing NF-kappaB, UPR and Akt/Notch pathways has potent anticancer activity in vitro and in vivo. PLoS One. 2016;11(3):e0149832. doi:10.1371/journal.pone.0149832
   PubMed Web of Science ®Google Scholar
• Li W, Wang L, Huang W, et al. Inhibition of ROS and inflammation by an imidazopyridine derivative X22 attenuate high fat diet-induced arterial injuries. Vascul Pharmacol. 2015;72:153–162. doi:10.1016/j.vph.2015.05.006
   PubMed Web of Science ®Google Scholar
• Ahsan N, Mishra S, Jain MK, Surolia A, Gupta S. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole)) curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant alpha-Synuclein. Sci Rep. 2015;5(1):9862. doi:10.1038/srep09862
   PubMedGoogle Scholar
• Qian Y, Zhong P, Liang D, et al. A newly designed curcumin analog Y20 mitigates cardiac injury via anti-inflammatory and antioxidant actions in obese rats. PLoS One. 2015;10(3):e0120215. doi:10.1371/journal.pone.0120215
   PubMed Web of Science ®Google Scholar
• Farrell GC, Chitturi S, Lau GKK, Sollano JD; Asia Pacific Working P. Guidelines for the assessment and management of nonalcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 2007;22(6):775–777. doi:10.1111/j.1440-1746.2007.05002.x
   PubMed Web of Science ®Google Scholar
• Hamonic G, Pasternak JA, Kaser T, Meurens F, Wilson HL. Extended semen for artificial insemination in swine as a potential transmission mechanism for infectious Chlamydia suis. Theriogenology. 2016;86(4):949–956. doi:10.1016/j.theriogenology.2016.03.018
   PubMed Web of Science ®Google Scholar
• Sun LN, Liu XC, Chen XJ, Guan GJ, Liu G. Curcumin attenuates high glucose-induced podocyte apoptosis by regulating functional connections between caveolin-1 phosphorylation and ROS. Acta Pharmacol Sin. 2016;37(5):645–655. doi:10.1038/aps.2015.159
   PubMed Web of Science ®Google Scholar
• Ejaz A, Wu D, Kwan P, Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr. 2009;139(5):919–925. doi:10.3945/jn.108.100966
   PubMed Web of Science ®Google Scholar
• Caprioglio D, Torretta S, Ferrari M, et al. Triazole-curcuminoids: a new class of derivatives for ‘tuning’ curcumin bioactivities? Bioorg Med Chem. 2016;24(2):140–152. doi:10.1016/j.bmc.2015.11.044
   PubMed Web of Science ®Google Scholar
• Ding L, Ma S, Lou H, Sun L, Ji M. Synthesis and biological evaluation of curcumin derivatives with water-soluble groups as potential antitumor agents: an in vitro investigation using tumor cell lines. Molecules. 2015;20(12):21501–21514. doi:10.3390/molecules201219772
   PubMed Web of Science ®Google Scholar
• Iranshahi M, Chini MG, Masullo M, et al. Can small chemical modifications of natural pan-inhibitors modulate the biological selectivity? The case of curcumin prenylated derivatives acting as HDAC or mPGES-1 inhibitors. J Nat Prod. 2015;78(12):2867–2879. doi:10.1021/acs.jnatprod.5b00700
   PubMed Web of Science ®Google Scholar
• Mehanny M, Hathout RM, Geneidi AS, Mansour S. Exploring the use of nanocarrier systems to deliver the magical molecule; Curcumin and its derivatives. J Control Release. 2016;225:1–30.
   PubMed Web of Science ®Google Scholar
• Morales NP, Sirijaroonwong S, Yamanont P, Phisalaphong C. Electron paramagnetic resonance study of the free radical scavenging capacity of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull. 2015;38(10):1478–1483. doi:10.1248/bpb.b15-00209
   PubMed Web of Science ®Google Scholar
• Pany S, Majhi A, Das J. Selective Modulation of Protein kinase C alpha over protein kinase C epsilon by curcumin and its derivatives in CHO-K1 cells. Biochemistry. 2016;55(14):2135–2143. doi:10.1021/acs.biochem.6b00057
   PubMed Web of Science ®Google Scholar
• Sahu PK, Sahu PK, Sahu PL, Agarwal DD. Structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives. Bioorg Med Chem Lett. 2016;26(4):1342–1347. doi:10.1016/j.bmcl.2015.12.013
   PubMed Web of Science ®Google Scholar
• Panzhinskiy E, Hua Y, Lapchak PA, et al. Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance. J Pharmacol Exp Ther. 2014;349(2):248–257. doi:10.1124/jpet.113.208728
   PubMed Web of Science ®Google Scholar
• Jimenez-Flores LM, Lopez-Briones S, Macias-Cervantes MH, Ramirez-Emiliano J, Perez-Vazquez V. A PPARgamma, NF-kappaB and AMPK-dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db/db mice liver. Molecules. 2014;19(6):8289–8302. doi:10.3390/molecules19068289
   PubMed Web of Science ®Google Scholar
• Ning C, Liu L, Lv G, et al. Lipid metabolism and inflammation modulated by Vitamin D in liver of diabetic rats. Lipids Health Dis. 2015;14(1):31. doi:10.1186/s12944-015-0030-5
   PubMedGoogle Scholar
• Yao QY, Xu BL, Wang JY, Liu HC, Zhang SC, Tu CT. Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats. BMC Complement Altern Med. 2012;12(1):156. doi:10.1186/1472-6882-12-156
   PubMedGoogle Scholar
• Qiang G, Yang X, Xuan Q, et al. Salvianolic Acid a prevents the pathological progression of hepatic fibrosis in high-fat diet-fed and streptozotocin-induced diabetic rats. Am J Chin Med. 2014;42(05):1183–1198. doi:10.1142/S0192415X14500748
   PubMedGoogle Scholar
• Toblli JE, Munoz MC, Cao G, Mella J, Pereyra L, Mastai R. ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats. Obesity. 2008;16(4):770–776. doi:10.1038/oby.2007.114
   PubMed Web of Science ®Google Scholar
• Chen L, Li L, Chen J, et al. Oleoylethanolamide, an endogenous PPAR-alpha ligand, attenuates liver fibrosis targeting hepatic stellate cells. Oncotarget. 2015;6(40):42530–42540. doi:10.18632/oncotarget.6466
   PubMedGoogle Scholar
• Zhou H, Fang C, Zhang L, Deng Y, Wang M, Meng F. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes. Chin Med J. 2014;127(2):225–231.
   PubMed Web of Science ®Google Scholar
• Yamamoto E, Dong Y-F, Kataoka K, et al. Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition. Hypertension. 2008;52(3):573–580. doi:10.1161/HYPERTENSIONAHA.108.112292
   PubMed Web of Science ®Google Scholar
• Gruson D, Thys F, Verschuren F. Diagnosing destabilized heart failure in the emergency setting. Mol Diagn Ther. 2011;15(6):327–340. doi:10.1007/BF03256468
   PubMed Web of Science ®Google Scholar
• Chen G, Wang R, Chen H, Wu L, Ge RS, Wang Y. Gossypol ameliorates liver fibrosis in diabetic rats induced by high-fat diet and streptozocin. Life Sci. 2016;149:58–64. doi:10.1016/j.lfs.2016.02.044
   PubMed Web of Science ®Google Scholar
• Huang SS, Chen DZ, Wu H, et al. Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis. Eur J Pharmacol. 2016;779:22–23. doi:10.1016/j.ejphar.2016.02.067
   PubMed Web of Science ®Google Scholar
• Tarantino G, Balsano C, Santini SJ, et al. It is high time physicians thought of natural products for alleviating NAFLD. Is there sufficient evidence to use them? Int J Mol Sci. 2021;22(24):13424. doi:10.3390/ijms222413424
   PubMed Web of Science ®Google Scholar